2002-2005

2005 - Pursaethosides A-E, triterpene saponins from Entada pursaetha

A.L. Tapondjou, T. Miyamoto, J-F. Mirjolet, N. Guilbaud and M.A. Lacaille-Dubois
J. Nat. Prod., 2005 Aug 26, 68(8): 1185-1190

EN SAVOIR PLUS
2005 - A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein

M. Tychopoulos, L. Corcos, P. Genne, P. Beaune and I. de Waziers
Cancer Gene Ther., 2005 May, 12(5): 497-508

EN SAVOIR PLUS
2005 - Tumor penetration of gefitinib (Iressa), an epidermal growth factor receptor tyrosine kinase inhibitor

D. McKillop, E.A. Partridge, J.V. Kemp, M.P. Spence, J. Kendrew, S. Barnett, P.G. Wood, P.B. Giles,
A.B. Patterson, F. Bichat, N. Guilbaud and T.C. Stephens
Mol. Cancer Ther., 2005 Apr, 4(4): 641-9

EN SAVOIR PLUS
2005 - Activation of GPR54 promotes cell cycle arrest and apoptosis of human tumor cells through a specific transcriptional program not shared by other Gq-coupled receptors

J.A. Becker, J.F. Mirjolet, J. Bernard, E. Burgeon, M.J. Simons, G. Vassart, M. Parmentier and F. Libert
Biochem. Biophys. Res. Commun., 2005 Jan 21, 326(3): 677-86

EN SAVOIR PLUS
2005 - Role of non invasive animal imaging in preclinical anticancer drug development (French review)

N. Guilbaud, O. Duchamp, N. Just and P. Genne
Bulletin du Cancer, 2005, 92(1): 45-57

EN SAVOIR PLUS
2003 - Rationale supporting the use of vasoconstrictors for intraperitoneal chemotherapy with platinum derivatives (Review)

B. Chauffert, P. Favoulet, E. Polycarpe, C. Duvillard, J.L. Beltramo, F. Bichat, P. Rat, P. Genne and L. Benoit
Surg. Oncol. Clin. N. Am., 2003 Jul, 12(3): 835-48

EN SAVOIR PLUS
2003 - Oncoprotein expression of E6 and E7 does not prevent 5-fluorouracil (5FU) mediated G1/S arrest and apoptosis in 5FU resistant carcinoma cell lines

C. Didelot, J.F. Mirjolet, M. Barberi-Heyob, C. Ramacci, M.H. Teiten and J.L. Merlin
Int. J. Oncol., 2003 Jul, 23(1): 81-7

EN SAVOIR PLUS
2003 - Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids

V. Wittamer, J.D. Franssen, M. Vulcano, J.F. Mirjolet, E. Le Poul, I. Migeotte, S. Brezillon, R. Tyldesley,
C. Blanpain, M. Detheux, A. Mantovani, S. Sozzani, G. Vassart, M. Parmentier and D. Communi
J. Exp. Med., 2003 Oct 6, 198(7): 977-85

EN SAVOIR PLUS
2002 - Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studies

O. Mazor, M. Hillairet de Boisferon, A. Lombet, A. Gruaz-Guyon, B. Gayer, D. Skrzydelsky, F. Kohen,
P. Forgez, A. Scherz, W. Rostène and Y. Salomon
Analytical Biochemistry, 2002 Feb 1, 301(1): 75-81

EN SAVOIR PLUS
2002 - G(1)/S but not G(0)/G(1)cell fraction is related to 5-fluorouracil cytotoxicity

J.F. Mirjolet, C. Didelot, M. Barberi-Heyob and J.L. Merlin
Cytometry, 2002 May 1, 48(1): 6-13

EN SAVOIR PLUS
2002 - Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model

M. Hillairet de Boisferon., O. Raguin, C. Thiercelin, M. Dussaillant, W. Rostène, J. Barbet,
A. Pélegrin and A. Gruaz-Guyon
Bioconjug. Chem., 2002 May-Jun, 13(3): 654-62

EN SAVOIR PLUS
2002 - Radiation could induce p53-independent and cell cycle-unrelated apoptosis in 5-fluorouracil radiosensitized head and neck carcinoma cells

C. Didelot, J.F. Mirjolet, M. Barberi-Heyob, C. Ramacci and J.L. Merlin
Canadian Journal of Physiological Pharmacology, 2002 Jul, 80(7): 638-43

EN SAVOIR PLUS
2002 - Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts

H. Gourdeau, P. Genne, S. Kadhim, L. Bibeau, O. Duchamp, F. Ouellet, J.M. deMuys, D.Y. Bouffard and G. Attardo
Cancer Chemotherapy Pharmacology, 2002 Dec, 50(6): 490-6

EN SAVOIR PLUS